Biocon Limited (BIOCON) Share Price
NSE · Healthcare · Biotechnology · ISIN INE376G01013
Key metrics
- Market Cap
- ₹66,939 Cr
- P/E Ratio
- 121.99
- EPS
- 3.37
- Book Value
- 225.93
- P/B Ratio
- 1.84
- ROE
- 1.05%
- ROCE
- 3.31%
- Debt / Equity
- 0.42
- Net Margin
- 2.3%
- Revenue Growth
- 11.48%
- Profit Growth
- -61.95%
- Dividend Yield
- 0.12%
- 52W High
- ₹447.15
- 52W Low
- ₹337.05
- Market Cap Band
- large cap
- Face Value
- 5
Ratios computed from the annual results period ending 2026-03-31.
About Biocon Limited
Biocon Limited, together with its subsidiaries, manufactures biotechnology products and offers research services in India, the United States, Ireland, rest of the European Union, and internationally. It operates through Generics; Biosimilars; and Contract Research, Development and Manufacturing Organization (CRDMO) segments. The company offers generic formulations and API products, including cardiovascular, anti-diabetics, obesity, central nervous system, anti-cancer/oncology, multiple sclerosis, immunosuppressants, and specialty molecules; and biosimilars products for oncology, diabetes, and immunology therapeutic areas. It also provides integrated discovery, development, and manufacturing services to pharmaceutical, biotechnology, animal health, consumer goods, and specialty chemical industries, as well as academic institutions, non-profit organizations, and government agencies. In addition, the company offers enzyme, biopharmaceutical, and medicinal goods; contract research and manufacturing services; clinical research; and business support and development, and marketing services. Biocon Limited was incorporated in 1978 and is headquartered in Bengaluru, India.
- Headquarters
- Bengaluru, India
- Employees
- 16,447
- Promoter Holding
- 48.12%
The full Biocon Limited analysis
Create a free account to open the complete BIOCON deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.